Alterity Therapeutics (ATHE) Asset Utilization Ratio (2017 - 2019)

Alterity Therapeutics' Asset Utilization Ratio history runs 3 years deep, the most recent figure standing at 0.35 for Q4 2019.

• On a quarterly basis, Asset Utilization Ratio rose 56168.79% year-over-year to 0.35 in Q4 2019; TTM through Dec 2019 was 0.35, a 56168.79% increase from a year earlier, with the FY2023 full-year figure at 0.0, down 100.0% from the prior year.
• Asset Utilization Ratio rose to 0.35 in Q4 2019 per ATHE's latest filing, from 0.0 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.35 in Q4 2019 and bottomed at 0.0 in Q4 2017.
• The 3-year median for Asset Utilization Ratio is 0.0 (2018), against an average of 0.12.
• Across the five-year window, Asset Utilization Ratio jumped 263.13% in 2018 and jumped 56168.79% in 2019, its largest moves.
• Year by year, Asset Utilization Ratio stood at 0.0 in 2017, then soared by 263.13% to 0.0 in 2018, then soared by 56168.79% to 0.35 in 2019.
• Per Business Quant, the three latest ATHE Asset Utilization Ratio figures stand at 0.35 (Q4 2019), 0.0 (Q4 2018), and 0.0 (Q4 2017).